SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Georgia O'Keeffe — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeorgia O'Keeffe
Date of birth1887-11-15
IdentifiersMRN HR-ET011-SYN-TD; SSN (made up) 000-11-5873
Document date1968-04-09
AuthorWendell Ashby, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week retina visit and second loading injection, left eye. [S]

History of Present Illness

Ms. O'Keeffe returns four weeks after her first aflibercept injection. Lines on her canvases look less bent with the left eye, and the gray spot is smaller. She had a small red patch on the white of the eye after the injection that faded within a week, and no pain, redness, or loss of vision. Her daily Amsler checks show no change in the right eye. She takes the AREDS2 supplement every day and is still painting daily. [S]

ElementDetail
Interval changeLess distortion and a smaller central spot in the left eye
After the first injectionSmall red patch on the white of the eye that faded within a week; no pain or vision loss
Amsler gridDaily checks; right eye unchanged
AdherenceAREDS2 supplement daily

Review of Systems

SystemResultFinding
EyesPositiveMilder distortion in the left eye; no pain, light sensitivity, flashes, or floaters
ConstitutionalNegativeNo fatigue or weight change
PsychiatricNegativeEncouraged by the change; sleeping well

3 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1968-04-09Body height165cmS
1968-04-09Body weight55.5kgS
1968-04-09Body mass index (BMI) [Ratio]20.4kg/m2S
1968-04-09Systolic blood pressure128mm[Hg]S
1968-04-09Diastolic blood pressure72mm[Hg]S
1968-04-09Heart rate68/minS
1968-04-09Respiratory rate14/minS
1968-04-09Body temperature36.6CelS
1968-04-09Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1968-04-09Visual acuity best corrected Left eye by ETDRS eye chart64{letters}>=80LowS
1968-04-09Macular grid.center subfield thickness by OCT322um200-300 umHighS
1968-04-09Left eye Intraocular pressure15mm[Hg]10-21 mmHgNormalS

Physical Exam

Vital signs recorded on 1968-04-09; see the Vital Signs section. [S]

SystemFinding
Visual acuityBest-corrected 64 letters left, up from 55
Intraocular pressure15 mmHg left before injection
Anterior segmentQuiet; no inflammation after the first injection
Dilated fundus, left eyeLesion smaller, with less subretinal fluid
Dilated fundus, right eyeLarge drusen unchanged; no fluid or hemorrhage
OCT, left eyeResidual subretinal fluid; central subfield thickness 322 µm, down from 418
After injection, left eyeOptic nerve head perfused; counts fingers; no pain

Problems

ProblemClinical statusVerificationCodeProvenance
Neovascular (wet) age-related macular degeneration, left eye, with active choroidal neovascularizationactiveconfirmed H35.3221S — Synthetic modern diagnosis linked to her documented failing eyesight; the historical type of macular degeneration is not recorded.
Nonexudative age-related macular degeneration, right eye, intermediate stageactiveconfirmed H35.3112S — Synthetic finding in the fellow eye.
New distortion (wavy lines) and a blurred central spot with reduced acuity in the left eye; suspected neovascular macular degeneration, urgent retina referralresolvedconfirmed H53.15S — Synthetic presenting concern at the index visit, superseded by the OCT diagnosis at the retina consultation; her failing eyesight is documented (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBest-corrected visual acuity (ETDRS letters)Every injection visitCompleted todayLeft 64 letters, up 9 from baseline. The right eye is followed by Amsler grid and dilated examination during loading
ImagingOptical coherence tomography of the maculaEvery injection visitCompleted todayLeft eye: central subfield thickness 322 µm with residual fluid
ExaminationIntraocular pressure before and after injectionEvery injection visitCompleted todayBefore injection 15 mmHg left; after injection, optic nerve perfused and counting fingers
ImagingFluorescein angiography or OCT angiographyIf the response is poor or the picture atypicalNot indicatedResponding as expected to loading, which supports the diagnosis
ExaminationDilated examination of the fellow (right) eyeEvery injection visitCompleted todayLarge drusen unchanged; no fluid
Medication safetyIntravitreal injection safetyEvery injection visitCompleted todaySmall subconjunctival hemorrhage after the first injection, resolved; no inflammation. Second loading dose today
Self-managementTeaching on warning signs of endophthalmitis and retinal detachmentEvery injection visitCompleted todayReviewed again
Self-managementDaily home Amsler grid, each eyeDailyCompleted todayDaily checks recorded; no change in the right eye
Medication safetyAREDS2 supplement for intermediate AMDDaily, long termCompleted todayTaking it daily
ReferralLow-vision rehabilitation, with home fall-risk review and a driving assessmentOnce central vision is reduced; review as vision changesReferredEvaluation booked for next month
SurveyDepression screen (PHQ-2)At follow-up, because vision loss raises the risk of depression; periodically at 65 or olderDuePlanned at the July primary care review

Goal progress:

Guideline basis: Age-Related Macular Degeneration Preferred Practice Pattern (2024); CMID: Clinical Monitoring Intelligence Database, cataract and glaucoma monographs (eye-examination items) (2026)

Follow-up: Retina visit in four weeks for the third loading injection. Next scheduled visit 1968-05-07: eight-week retina follow-up with OCT and third injection. [S]